Lei Feng

Lei Feng is currently the Associate Director at Kodikaz Therapeutic Solutions, Inc, with previous experience as a Senior Scientist at MeiraGTx. Lei created a platform for high throughput screening libraries in mammalian cells and identified riboswitches that are significantly more effective than previous reports. With a background in post-doctoral research at Albert Einstein College of Medicine, Lei developed and optimized a technique for in situ fucosylation, both in vitro and in vivo. Lei also holds a Ph.D. in MCB from the University of Washington.